What is drug addiction? Considerable confusion exists regarding
the nature of addiction. The most common misunderstanding is that addiction
refers to a state of physical dependence on a drug whereby discontinuing
drug intake produces a withdrawal syndrome consisting of various somatic
disturbances. Addiction is better defined as a behavioral syndrome
where drug procurement and use seem to dominate the individual’s motivation
and where the normal constraints on behavior are largely ineffective.
This condition may or may not be accompanied by the development of physical
dependence on the drug. This condition has also been described as a "psychological"
addiction (thus distinguishing it from physical dependence archaically
termed "physical" addiction), but confusion is minimized by using the term
addiction to refer to the behavioral syndrome described above and the term
physical dependence to refer to the condition associated with somatic withdrawal
reactions. The distinguishing feature of the condition commonly referred
to as addiction is the ability of the drug to dominate the individual’s
behavior, regardless of whether physical dependence is also produced by
the drug.
|
|
What causes drug addiction? Many factors influence a person’s
initial drug use. Personality characteristics, peer pressure, and psychological
stress can all contribute to the early stage of drug abuse. These factors
are less important as drug use continues and the person repeatedly experiences
the potent pharmacological effects of the drug. This chemical action, which
stimulates certain brain systems, produces the addiction, while other psychological
and social factors become less and less important in influencing the individual’s
behavior. When the pharmacological action of a drug dominates the individual’s
behavior and the normal psychological and social control of behavior is
no longer effective, the addiction is fully developed. This self-perceived
"loss of control" is a common feature of drug addiction and reflects the
biological nature of the problem.
|
Biological Basis of Addiction |
How is drug addiction related to "normal" behavior? Specialized
brain systems have evolved to ensure survival of the species. These systems
direct behavior by rewarding actions that promote survival of the individual
and of the species. Intake of nutrients and procreation are governed by
specific brain systems; for example, the interaction of various substances
in foods (e.g., sugars, fats) activate taste receptors which in turn activate
brain reward mechanisms. Activation of brain reward systems produces changes
in affect ranging from slight mood elevation to intense pleasure and euphoria,
and these psychological states help direct behavior toward natural rewards.
Some chemicals activate brain reward systems directly, bypassing the sensory
receptors mediating natural rewards. The caffeine from coffee and tea,
the alcohol from fermented beverages, and the nicotine from tobacco all
activate brain reward mechanisms directly. Moderate use of these substances
has gained widespread acceptance over the centuries, although their use
has been periodically prohibited (e.g., alcohol during prohibition) or
restricted (e.g., cigarette smoking currently). Other drugs much more potently
activate brain reward systems. Initial use of these substances is usually
accompanied by mood elevation and other affective changes that lead to
their recreational use. (Some drugs have actions that produce other desirable
psychological effects, such as relaxation.) Much like moderate caffeine
and alcohol use, addictive drugs activate brain reward systems. But the
activation is much more intense causing the individual to crave the drug
and to focus their activities around taking the drug. The ability of addictive
drugs to strongly activate brain reward mechanisms and their ability to
chemically alter the normal functioning of these systems can produce an
addiction.
|
|
What are psychoactive drugs? Many drugs interact with brain mechanisms
involved in affect, cognition, and behavior. These compounds are termed
psychoactive drugs. Drugs are usually classified according to their primary
therapeutic actions. Antipsychotic drugs are used to treat schizophrenia
and produce a normalization of the disordered thought processes associated
with this illness. Antidepressant drugs are used to treat psychological
depression and produce a normalization of disturbed affective states characteristic
of depression. And antianxiety drugs (i.e., anxiolytics) are used to treat
anxiety and produce a calming action in nervous individuals. These and
numerous other drugs have important clinical uses and have revolutionized
the treatment of many mild to severe mental disorders. Some work at the
ASnet and its laboratory facility—the Addiction Research Unit (ARU) at
the University at Buffalo—investigates the actions of these drugs, but
research focuses on psychoactive drugs that are addictive. Recent work
has also investigated the effects of mildly psychoactive compounds found
in over-the-counter medicines (e.g., pseudoephedrine, diphenhydramine)
and compares their effects with prototypic addictive drugs (e.g., cocaine,
heroin). This comparison helps sharpen the distinction between addictive
and nonaddictive substance use and is used in comparing the effects of
other commonly used substances (i.e., caffeine, nicotine).
|
|
Why conduct basic scientific research? Although the basic biological actions of some drugs are well understood, many important questions remain to be answered. Why do individuals differ in their vulnerability to addiction? How do psychological factors such as stress interact with brain mechanisms to influence the development of an addiction? And why are some people successful in overcoming their addiction while others are not? (Certainly differences in treatment approaches do not account for the successes, because no single treatment program has a uniquely high success rate.) These and many other questions need to be answered. Considerable progress has been made during the past two decades, but considerable more work needs to be done before drug addiction is fully understood. And understanding addiction is the key to successful treatment.
What is the most effective approach to conducting basic research
in drug addiction? Two important considerations direct research at
ASnet into basic mechanisms of drug addiction. First, research focuses
on prototypic addiction drugs. These are drugs with a high addiction liability
(i.e., addiction develops quickly and in a high percentage of individuals
after relatively brief use). Prototypic addictive drugs also have well-defined
actions on biological systems (i.e., interact with specific brain systems)
and have historically shown epidemic patterns of abuse (i.e., abuse patterns
showing rapid increases in the number of people using the drug during the
past century often followed by a marked decline in use; a cyclic pattern
of abuse). The two drug classes that clearly fit these criteria for prototypic
addictive drugs are the psychomotor stimulants (e.g., amphetamine, cocaine,
methamphetamine) and the opiates (e.g., heroin, morphine). Second, animal
models are used to study the underlying biological mechanisms of addiction.
Laboratory animals voluntarily self-administer these prototypic addictive
drugs, and basic research in drug addiction uses animal models to study
the biological mechanisms underlying addiction. (Contrary to popular belief,
laboratory animals exposed to addictive drugs usually remain healthy and
suffer no adverse effects of these drugs [i.e., low morbidity]. The only
experiments where research animals are subjected to any appreciable discomfort
involve those studying the effects of psychological stress or continuous
exposure to drugs. Few experiments are conducted at the ARU investigating
these experimental conditions, and all studies are conducted with laboratory
rats.) As basic research studying prototypic addictive drugs in animal
models progresses, the principles learned with this approach are extended
to other addictive drugs (e.g., alcohol) and to clinical studies (e.g.,
the treatment of drug addicts).
|
used to study drug addiction |
Are there other benefits from studying addiction? Understanding the underlying neural basis of addiction opens the door to not only treating specific drug addictions but to also understanding fundamental relationships between behavior and brain function. Addiction presents a situation where chemical activation of brain mechanisms control the individual's behavior, and understanding this process helps delineate processes involved in normal behavior. In addition, several mental disorders, such as schizophrenia and depression, involve disturbances in the same brain system as that involved in addiction. Basic research provides the key to deciphering the biological basis of addiction and to understanding other types of psychopathology.
Why develop medications for treating addiction? Drug addiction involves disturbances in brain chemistry caused by repeated use of certain psychoactive substances. Although the exact nature of these disturbances is not well understood (and hence, the need for continued basic research), the biological nature of this problem is appreciated by most specialists. Psychological counseling and therapy can help the individual recovering from addiction, but the main problem lies with altered brain chemistry that needs to be treated pharmacologically. A number of medications are currently being investigated in various laboratories, but none are yet very effective. Basic research studying prototypic addictive drugs in animal models can identify the neural mechanisms underlying addiction. This information can then direct the development of medications for the treatment of addiction. These medications are evaluated for their safety and effectiveness using animal models before being prescribed clinically to treat addiction. (This last step is particularly important, considering that heroin was originally developed as a treatment for morphine addiction.)
What's wrong with the current sources of information regarding addiction?
A number of agencies and organizations disseminate information about drug
addiction (for examples, see the Links
on the ARU home page). Most
notably, the National Institute on Drug Abuse (NIDA) has been the premier
clearing house for information on drug abuse. Many excellent research monographs,
pamphlets, and press releases are sponsored by NIDA, but this government
organization must also respond to the political realities of all government
organizations. When marijuana use in the late 1940s became a national concern,
the government was involved in producing a film entitled Reefer Madness
to "educate" the public about the dangers of marijuana use. This film remains
a classic today, but not as a testimony to unbiased presentation of scientific
evidence; rather; this film exemplifies the propaganda expounded by a politically
directed organization and has fostered the distrust that many young people
have of government information. More recently, NIDA diverted attention
from cocaine and heroin addiction when the Surgeon General declared "nicotine
more addictive than cocaine." Although this assertion seems to have been
quietly accepted by many scientists, the ASnet considers this statement
unsubstantiated by the empirical data and socially irresponsible. Dissident
opinion has been silenced by the feared repercussions of challenging official
government policy. Other, nongovernment organizations providing information
regarding drug abuse also have hidden agendas. Most are linked with treatment
centers, pharmaceutical firms selling a product, or supported by government
grants and contracts. Much of the information disseminated from these sources
is accurate, but some of it is not. Although the ASnet is in principle
opposed to any illicit substance use, it follows the dictum that unbiased
scientific information should be provided to the public. It is the responsibility
of science to provide the facts of the individual to decide how to use
those facts.
| Need more information?
Click here to search the Addiction Research Unit web site at the University at Buffalo. |
|
|